Association between per- and polyfluoroalkyl substances and risk of gestational diabetes mellitus.

Abstract

Existing evidence suggests that perfluoroalkyl and polyfluoroalkyl substances (PFASs) exposure might contribute to the incidence of gestational diabetes mellitus (GDM). This study aimed to perform a meta-analysis to identify the association between PFAS and the risk of GDM. We systematically searched PubMed, Ovid, Cochrane Library, and Web of Science databases for appropriate articles about the association between PFASs exposure and the risk of GDM before September 28, 2020. Odds ratios (OR) with 95% confidence intervals (CIs) were summarized by Stata 16.0 through fixed effect models according to heterogeneity. We also carried out subgroup analyses by geographic location, blood sampling time of subjects, method of chemical analysis, study design, sample size, and sampling year. In addition, a sensitivity analysis was conducted to explore the robustness of the results. A total of eight studies involving 5654 pregnant women were included in the meta-analysis. Perfluorooctanoic acid (PFOA) exposure was positively and significantly associated with the risk of GDM (OR=1.27, 95% CI: 1.02-1.59). Exposure to other types of PFASs such as perfluorooctane sulfonate (PFOS), perfluorohexane sulfonate (PFHxS), perfluorononanoic acid (PFNA) was not statistically significantly associated with the risk of GDM with the pooled effect estimates of 0.97 (95% CI: 0.86-1.09), 1.03 (95% CI: 0.86-1.24), and 0.80 (95% CI: 0.55-1.16) respectively. We conducted a meta-analysis to investigate the association between PFASs exposure and GDM and found that PFOA concentration was significantly associated with a higher risk of GDM, which is of great significance for the prevention and control of GDM in public health. Further studies are needed in order to establish causality and clarify the potential mechanism.